Abemaciclib plus letrozole shows clinically meaningful activity in patients with advanced or recurrent endometrioid endometrial cancer in a phase 2 trial.
A new USC-led study using functional magnetic resonance imaging (fMRI) reveals the neural mechanisms that contribute to ...